Literature DB >> 30504679

Novel Strategy for the Systemic Delivery of Furosemide Based on a New Drug Transport Mechanism.

Shunsuke Kimura1, Akiko Kiriyama1, Erika Nishimura1, Shiori Sakata1, Daisuke Inoue2, Tomoyuki Furubayashi2, Reiko Yutani3, Akiko Tanaka3, Kosuke Kusamori4, Hidemasa Katsumi4, Katsumi Iga1, Akira Yamamoto4, Toshiyasu Sakane3.   

Abstract

We reported a novel transport mechanism of curcumin, independent of improved solubility, which involved direct contact of amorphous solid particles with the cell membrane. This mechanism has potential as a novel systemic delivery system of poorly water-soluble drugs. In this study, the transport mechanism of furosemide (FUR), which is transported by the same novel mechanism, was examined. In vitro cell permeation studies under air-interface conditions (AICs) revealed that the permeation from powders sprayed on cell monolayers was significantly higher than that under liquid-covered conditions (LCCs) from their solutions. The permeation from amorphous solid particles was faster than that from crystals. Similar results were derived from in vitro studies using an artificial membrane, with which the permeation of FUR could be examined without water. These findings clearly indicated that the transport mechanism of FUR is the same as that of curcumin. For the application of this new transport mechanism, the in vivo absorption of FUR was examined after pulmonary insufflation, which allows the solid particles to make direct contact with the epithelial cells. Pulmonary absorption of FUR from the amorphous powder was almost complete and was faster than that after intragastric administration of the solution, suggesting that FUR was absorbed from the lung by the same mechanism as the in vitro study. This new transport mechanism, which is independent of water dissolution, could be exploited to develop a novel delivery system for poorly water-soluble drugs, using pulmonary powder inhalation.

Entities:  

Keywords:  amorphous solid particle; dry powder formulation; furosemide; pulmonary absorption

Mesh:

Substances:

Year:  2018        PMID: 30504679     DOI: 10.1248/bpb.b18-00315

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  1 in total

1.  Development and Characterization of Eudragit®-Based Electrospun Nanofibrous Mats and Their Formulation into Nanofiber Tablets for the Modified Release of Furosemide.

Authors:  Marilena Vlachou; Stefanos Kikionis; Angeliki Siamidi; Sotiria Kyriakou; Andrew Tsotinis; Efstathia Ioannou; Vassilios Roussis
Journal:  Pharmaceutics       Date:  2019-09-17       Impact factor: 6.321

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.